James A. Mbah
University of Buea
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James A. Mbah.
PLOS ONE | 2013
Fidele Ntie-Kang; Denis Zofou; Smith B. Babiaka; Rolande Meudom; Michael Scharfe; Lydia L. Lifongo; James A. Mbah; Luc Meva’a Mbaze; Wolfgang Sippl; Simon M. N. Efange
Computer-aided drug design (CADD) often involves virtual screening (VS) of large compound datasets and the availability of such is vital for drug discovery protocols. We assess the bioactivity and “drug-likeness” of a relatively small but structurally diverse dataset (containing >1,000 compounds) from African medicinal plants, which have been tested and proven a wide range of biological activities. The geographical regions of collection of the medicinal plants cover the entire continent of Africa, based on data from literature sources and information from traditional healers. For each isolated compound, the three dimensional (3D) structure has been used to calculate physico-chemical properties used in the prediction of oral bioavailability on the basis of Lipinski’s “Rule of Five”. A comparative analysis has been carried out with the “drug-like”, “lead-like”, and “fragment-like” subsets, as well as with the Dictionary of Natural Products. A diversity analysis has been carried out in comparison with the ChemBridge diverse database. Furthermore, descriptors related to absorption, distribution, metabolism, excretion and toxicity (ADMET) have been used to predict the pharmacokinetic profile of the compounds within the dataset. Our results prove that drug discovery, beginning with natural products from the African flora, could be highly promising. The 3D structures are available and could be useful for virtual screening and natural product lead generation programs.
BMC Complementary and Alternative Medicine | 2013
Fidele Ntie-Kang; James A. Mbah; Luc Meva’a Mbaze; Lydia L. Lifongo; Michael Scharfe; Joelle Ngo Hanna; Fidelis Cho-Ngwa; Pascal Amoa Onguéné; Luc C. Owono Owono; Eugene Megnassan; Wolfgang Sippl; Simon M. N. Efange
BackgroundComputer-aided drug design (CADD) often involves virtual screening (VS) of large compound datasets and the availability of such is vital for drug discovery protocols. We present CamMedNP - a new database beginning with more than 2,500 compounds of natural origin, along with some of their derivatives which were obtained through hemisynthesis. These are pure compounds which have been previously isolated and characterized using modern spectroscopic methods and published by several research teams spread across Cameroon.DescriptionIn the present study, 224 distinct medicinal plant species belonging to 55 plant families from the Cameroonian flora have been considered. About 80 % of these have been previously published and/or referenced in internationally recognized journals. For each compound, the optimized 3D structure, drug-like properties, plant source, collection site and currently known biological activities are given, as well as literature references. We have evaluated the “drug-likeness” of this database using Lipinski’s “Rule of Five”. A diversity analysis has been carried out in comparison with the ChemBridge diverse database.ConclusionCamMedNP could be highly useful for database screening and natural product lead generation programs.
In silico pharmacology | 2013
Fidele Ntie-Kang; Lydia L. Lifongo; James A. Mbah; Luc C. Owono Owono; Eugene Megnassan; Luc Meva’a Mbaze; Philip N. Judson; Wolfgang Sippl; Simon M. N. Efange
PurposeDrug metabolism and pharmacokinetics (DMPK) assessment has come to occupy a place of interest during the early stages of drug discovery today. The use of computer modelling to predict the DMPK and toxicity properties of a natural product library derived from medicinal plants from Central Africa (named ConMedNP). Material from some of the plant sources are currently employed in African Traditional Medicine.MethodsComputer-based methods are slowly gaining ground in this area and are often used as preliminary criteria for the elimination of compounds likely to present uninteresting pharmacokinetic profiles and unacceptable levels of toxicity from the list of potential drug candidates, hence cutting down the cost of discovery of a drug.In the present study, we present an in silico assessment of the DMPK and toxicity profile of a natural product library containing ~3,200 compounds, derived from 379 species of medicinal plants from 10 countries in the Congo Basin forests and savannas, which have been published in the literature. In this analysis, we have used 46 computed physico-chemical properties or molecular descriptors to predict the absorption, distribution, metabolism and elimination and toxicity (ADMET) of the compounds.ResultsThis survey demonstrated that about 45% of the compounds within the ConMedNP compound library are compliant, having properties which fall within the range of ADME properties of 95% of currently known drugs, while about 69% of the compounds have ≤ 2 violations. Moreover, about 73% of the compounds within the corresponding “drug-like” subset showed compliance.ConclusionsIn addition to the verified levels of “drug-likeness”, diversity and the wide range of measured biological activities, the compounds from medicinal plants in Central Africa show interesting DMPK profiles and hence could represent an important starting point for hit/lead discovery.
Journal of Natural Products | 2009
Simon M. N. Efange; Reto Brun; Sergio Wittlin; Thomas R. Hoye; Thomas McAkam; Felix L. Makolo; James A. Mbah; Dorian P. Nelson; Kennedy D Nyongbela; Clare Wirmum
Okundoperoxide (1) was isolated by bioassay-guided fractionation of extracts from Scleria striatinux (syn. S. striatonux). The compound contains a cyclic endoperoxide structural moiety and possesses moderate antimalarial activity.
Annals of Clinical Microbiology and Antimicrobials | 2012
James A. Mbah; Moses N. Ngemenya; Ashime Louis Abawah; Smith B. Babiaka; Lina N Nubed; Kennedy D Nyongbela; Njimoh Dieudonne Lemuh; Simon M. N. Efange
BackgroundThe global burden of bacterial infections is high and has been further aggravated by increasing resistance to antibiotics. In the search for novel antibacterials, three medicinal plants: Peperomia vulcanica, Peperomia fernandopoioana (Piperaceae) and Scleria striatinux (Cyperaceae), were investigated for antibacterial activity and toxicity.MethodsCrude extracts of these plants were tested by the disc diffusion method against six bacterial test organisms followed by bio-assay guided fractionation, isolation and testing of pure compounds. The minimum inhibitory (MIC) and minimum bactericidal (MBC) concentrations were measured by the microdilution method. The acute toxicity of the active extracts and cytotoxicity of the active compound were performed in mice and mammalian cells, respectively.ResultsThe diameter of the zones of inhibition (DZI) of the extracts ranged from 7–13 mm on Escherichia coli and Staphylococcus aureus of which the methylene chloride:methanol [1:1] extract of Scleria striatinux recorded the highest activity (DZI = 13 mm). Twenty-nine pure compounds were screened and one, Okundoperoxide, isolated from S. striatinux, recorded a DZI ranging from 10–19 mm on S. aureus. The MICs and MBCs indicated that the Peperomias had broad-spectrum bacteriostatic activity. Toxicity tests showed that Okundoperoxide may have a low risk of toxicity with an LC50 of 46.88 μg/mL.ConclusionsThe antibacterial activity of these plants supports their use in traditional medicine. The pure compound, Okundoperoxide, may yield new antibacterial lead compounds following medicinal chemistry exploration.
RSC Advances | 2015
Smith B. Babiaka; Fidele Ntie-Kang; Bakoh Ndingkokhar; James A. Mbah; Wolfgang Sippl; Joseph N. Yong
This review is intended to highlight the relevance of natural products in drug discovery paying particular attention to those derived from Southern African medicinal plants with diverse biological activities. In this review series, a literature survey led to the collection of 864 secondary metabolites from 101 plant species from 57 plant families. A correlation between the known biological activities of isolated compounds and the ethnobotanical uses of the plants has been attempted. Part I focused on alkaloids and terpenoids, while this part is focused on the bioactivities of flavonoids, quinines and other minor, unique compound classes which correlate with their ethnobotanical uses in African traditional medicine (ATM).
RSC Advances | 2015
Smith B. Babiaka; Fidele Ntie-Kang; Lydia L. Lifongo; Bakoh Ndingkokhar; James A. Mbah; Joseph N. Yong
As a whole, the African continent is highly endowed with a huge floral biodiversity. Natural products which have been isolated from plants growing in this region have shown interesting chemical structures with diverse biological activities, which could serve as a starting point for drug discovery. In this study, a literature survey led to the collection of 864 secondary metabolites from 101 plant species from 57 plant families. A correlation between the known biological activities of isolated compounds and the ethnobotanical uses of the plants has been attempted. This review is a survey of the bioactivities of alkaloids and terpenoids which have been isolated from Southern African flora versus the ethnobotanical uses of the plants used in Southern African traditional medicine.
European journal of medicinal plants | 2015
Moses N. Ngemenya; Haelly M. Metuge; James A. Mbah; Denis Zofou; Smith B. Babiaka; Vincent P.K. Titanji
Aims :This study investigated the antiplasmodial activity of crude extracts, fractions and pure isolates ofP. vulcanicaand P. fernandopoioana(Piperaceae). Toxicity and interaction between the most active natural products were also assessed. Study Design: Bioassay-guided approach was used to identify and further investigate the most active components against chloroquine -sensitive and resistant P. falciparumstrains. Place and Duration of Study:Departments of Biochemistry and Molecular Biology, Chemistry and Biotechnology Unit, Faculty of Science, University of Buea, Cameroon for one year. Methodology: Test substances were prepared fromthe two plants and screened on four strains of P. falciparum(chloroquine-sensitive 3D7, multidrug resistant W2mef and Dd2, and a field isolate
Organic and Medicinal Chemistry Letters | 2013
Fidele Ntie-Kang; James A. Mbah; Lydia L. Lifongo; Luc C. Owono Owono; Eugene Megnassan; Luc Meva’a Mbaze; Philip N. Judson; Wolfgang Sippl; Simon M. N. Efange
BMC Complementary and Alternative Medicine | 2014
Moses Samje; Jonathan Alunge Metuge; James A. Mbah; Brice Nguesson; Fidelis Cho-Ngwa